<?xml version="1.0" encoding="UTF-8"?>
<ref id="B17-molecules-26-01252">
 <label>17.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Imam</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Al-Harbi</surname>
    <given-names>N.O.</given-names>
   </name>
   <name>
    <surname>Al-Harbi</surname>
    <given-names>M.M.</given-names>
   </name>
   <name>
    <surname>Ansari</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Al-Asmari</surname>
    <given-names>A.F.</given-names>
   </name>
   <name>
    <surname>Ansari</surname>
    <given-names>M.N.</given-names>
   </name>
   <name>
    <surname>Al-Anazi</surname>
    <given-names>W.A.</given-names>
   </name>
   <name>
    <surname>Bahashwan</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Almutairi</surname>
    <given-names>M.M.</given-names>
   </name>
   <name>
    <surname>Alshammari</surname>
    <given-names>M.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Apremilast prevent doxorubicin-induced apoptosis and inflammation in heart through inhibition of oxidative stress mediated activation of NF-B signaling pathways</article-title>
  <source>Pharmacol. Rep.</source>
  <year>2018</year>
  <volume>70</volume>
  <fpage>993</fpage>
  <lpage>1000</lpage>
  <pub-id pub-id-type="doi">10.1016/j.pharep.2018.03.009</pub-id>
 </element-citation>
</ref>
